knowledge -WSS

knowledge

author：fashion 2025-09-28 23:51:14 - browse：7

A view of different flags of the European Union Members. -- first opinion coverage from STAT — Ronald Wittek, Pool Photo via AP

Today, the criteria used to assess the clinical value of new pharmaceuticals and medical devices varies widely across Europe, making it more challenging for biopharma companies to efficiently launch products in multiple countries and contributing to the disparities in access across the continent.

But change is on the horizon: In less than 15 months, the European Union will establish and begin to implement a standardized, pan-EU framework, which all 27 of member states will be required to use to assess the clinical evidence of newly submitted products or devices. A key pillar of the EU’s Regulation on Health Technology Assessment (HTA), the Joint Clinical Assessment (JCA) aims to establish a single, transparent process to reduce redundant practices and bring life science innovation faster to patients in Europe — no matter where they live.

In a longstanding problem in Europe, access to — and the availability of — medication varies across the member states. For example, in Germany, 87% of products approved by the European Medicines Agency (EMA) have full availability (the product gained access on the public reimbursement list without any restrictions to the patient population). In Poland, that figure drops to 8%, according to a report published by the European Federation of Pharmaceutical Industries. Meanwhile, there is a tremendous difference in the gap between an oncology therapy receiving marketing authorization and a formal positive reimbursement decision, ranging from an average of 86 days in Denmark to 981 days in Latvia.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Lack of darker skin in textbooks, journals harms patients of color

WSS

Phoenix breaks record with 19 consecutive days above 110 degrees Fahrenheit

Jesse Tyler Ferguson makes friendship bracelets for Taylor Swift's Eras Tour

New company forms to vet health AI models, root out weaknesses

Russian court extends detention of American musician

A look at other Americans who have crossed into North Korea over the years

House passes resolution saying Israel isn't a 'racist or apartheid state'

focus

knowledge

leisure time

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

US Marines prepare to be put on commercial ships to deter Iranian harassment in Strait of Hormuz

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Johnson & Johnson sues to stop Medicare negotiation

23andMe had bad news about my health. I wish a person had delivered it

Parkland mass shooting to be reenacted for lawsuit

In Memoriam: Notable people who died in 2023

Slain Parkland victim's father speaks out following reenactment

Bright Health sells Medicare Advantage business to Molina

Rock icon Freddie Mercury pre

leisure time

New company forms to vet health AI models, root out weaknesses

Rivals hope for voter 'fatigue' as Trump's woes mount but base stays loyal: ANALYSIS

BridgeBio heart drug succeeds in pivotal study

Jesse Tyler Ferguson makes friendship bracelets for Taylor Swift's Eras Tour

Jailed Russian opposition leader Alexey Navalny gets 19 more years in prison

Lack of darker skin in textbooks, journals harms patients of color

focus

Wikipedia

hotspot

hotspot